These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 37868956)

  • 1. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.
    Wang M; Yu F; Li P
    Front Immunol; 2023; 14():1269054. PubMed ID: 37868956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer.
    Sheng D; Yue K; Li H; Zhao L; Zhao G; Jin C; Zhang L
    Microbiol Spectr; 2023 Mar; 11(2):e0354922. PubMed ID: 36975828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
    Chen Y; Liu B; Wei Y; Kuang DM
    Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral microbiota: implications for cancer onset, progression, and therapy.
    Wu J; Zhang P; Mei W; Zeng C
    Front Immunol; 2023; 14():1301506. PubMed ID: 38292482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intratumoral microbiota: a new horizon in cancer immunology.
    Liu W; Li Y; Wu P; Guo X; Xu Y; Jin L; Zhao D
    Front Cell Infect Microbiol; 2024; 14():1409464. PubMed ID: 39135638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral bacteria are an important "accomplice" in tumor development and metastasis.
    Wang G; He X; Wang Q
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188846. PubMed ID: 36496095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
    Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
    Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the intratumoral microbiome in tumor progression and therapeutics implications.
    Meng YF; Fan ZY; Zhou B; Zhan HX
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189014. PubMed ID: 37918451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy.
    Yang L; Li A; Wang Y; Zhang Y
    Signal Transduct Target Ther; 2023 Jan; 8(1):35. PubMed ID: 36646684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional Mediation Effects between Intratumoral Microbiome and Host DNA Methylation Changes Contribute to Stomach Adenocarcinoma.
    Yue K; Sheng D; Xue X; Zhao L; Zhao G; Jin C; Zhang L
    Microbiol Spectr; 2023 Aug; 11(4):e0090423. PubMed ID: 37260411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
    Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
    Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer.
    Chen F; Yang J; Guo Y; Su D; Sheng Y; Wu Y
    Front Immunol; 2023; 14():1140995. PubMed ID: 36999009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abundance and Metabolism Disruptions of Intratumoral Microbiota by Chemical and Physical Actions Unfreeze Tumor Treatment Resistance.
    Kong F; Fang C; Zhang Y; Duan L; Du D; Xu G; Li X; Li H; Yin Y; Xu H; Zhang K
    Adv Sci (Weinh); 2022 Mar; 9(7):e2105523. PubMed ID: 35037431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral microbiome and gastrointestinal cancers.
    Li S; Li Q; Lu W
    Front Oncol; 2022; 12():1047015. PubMed ID: 36523986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
    Wang M; Zhang L; Chang W; Zhang Y
    Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microbiome - an integral part of the tumor microenvironment.
    Ciernikova S; Sevcikova A; Stevurkova V; Mego M
    Front Oncol; 2022; 12():1063100. PubMed ID: 36505811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?
    Kyriazi AA; Karaglani M; Agelaki S; Baritaki S
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral microbiota: new frontiers in tumor immunity.
    Zhang Z; Liao Y; Tang D
    Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
    Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
    Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
    Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.